The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The impact of targeted molecular therapy on the level of renal cell carcinoma (RCC) venous tumor thrombus.
N. G. Cost
No relevant relationships to disclose
S. E. Delacroix
No relevant relationships to disclose
J. P. Sleeper
No relevant relationships to disclose
P. J. Smith
No relevant relationships to disclose
R. F. Youssef
No relevant relationships to disclose
B. F. Chapin
No relevant relationships to disclose
J. A. Karam
No relevant relationships to disclose
S. H. Culp
No relevant relationships to disclose
E. J. Abel
No relevant relationships to disclose
J. Brugarolas
No relevant relationships to disclose
G. Raj
No relevant relationships to disclose
A. I. Sagalowsky
No relevant relationships to disclose
C. G. Wood
No relevant relationships to disclose
V. Margulis
No relevant relationships to disclose